| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Lenient versus strict rate control in patients with atrial fibrillation.
|
N Engl J Med
|
2010
|
8.17
|
|
2
|
Rosuvastatin in older patients with systolic heart failure.
|
N Engl J Med
|
2007
|
7.55
|
|
3
|
Apixaban with antiplatelet therapy after acute coronary syndrome.
|
N Engl J Med
|
2011
|
4.81
|
|
4
|
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.
|
N Engl J Med
|
2012
|
4.49
|
|
5
|
Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.
|
JAMA Intern Med
|
2013
|
3.46
|
|
6
|
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
|
J Am Coll Cardiol
|
2009
|
3.32
|
|
7
|
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
|
N Engl J Med
|
2011
|
3.20
|
|
8
|
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.
|
JAMA
|
2012
|
2.22
|
|
9
|
Percutaneous coronary intervention with off-site cardiac surgery backup for acute myocardial infarction as a strategy to reduce door-to-balloon time.
|
Am J Cardiol
|
2007
|
2.03
|
|
10
|
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.
|
Eur Heart J
|
2011
|
1.98
|
|
11
|
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.
|
Circulation
|
2010
|
1.96
|
|
12
|
Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
|
Circulation
|
2013
|
1.77
|
|
13
|
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial.
|
BMJ
|
2011
|
1.74
|
|
14
|
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.
|
Eur Heart J
|
2012
|
1.45
|
|
15
|
Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization.
|
J Nucl Med
|
2002
|
1.42
|
|
16
|
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.
|
EuroIntervention
|
2014
|
1.42
|
|
17
|
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.
|
Eur Heart J
|
2010
|
1.34
|
|
18
|
Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study.
|
Heart
|
2006
|
1.16
|
|
19
|
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
|
Eur J Heart Fail
|
2009
|
1.09
|
|
20
|
Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study.
|
Eur J Heart Fail
|
2005
|
0.94
|
|
21
|
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
|
Am Heart J
|
2006
|
0.89
|
|
22
|
Anatomical versus Functional Testing for Coronary Artery Disease.
|
N Engl J Med
|
2015
|
0.88
|
|
23
|
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial.
|
Am Heart J
|
2011
|
0.86
|
|
24
|
Safety and efficacy of a nurse-led clinic for post-operative coronary artery bypass grafting patients.
|
Int J Cardiol
|
2006
|
0.81
|
|
25
|
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.
|
Thromb Haemost
|
2014
|
0.80
|
|
26
|
The prognostic value of markers of inflammation in patients with troponin T-negative chest pain before discharge from the emergency department.
|
Am J Med
|
2003
|
0.79
|
|
27
|
Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?
|
Thromb Haemost
|
2012
|
0.77
|
|
28
|
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial.
|
Am Heart J
|
2013
|
0.76
|
|
29
|
High-pitch prospective ECG-triggered helical coronary computed tomography angiography in clinical practice: image quality and radiation dose.
|
Int J Cardiovasc Imaging
|
2014
|
0.76
|
|
30
|
Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial.
|
J Invasive Cardiol
|
2013
|
0.75
|
|
31
|
Discriminative Power of the HEART Score for Obstructive Coronary Artery Disease in Acute Chest Pain Patients Referred for CCTA.
|
Crit Pathw Cardiol
|
2016
|
0.75
|
|
32
|
Infarct size in primary angioplasty without on-site cardiac surgical backup versus transferal to a tertiary center: a single photon emission computed tomography study.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.75
|
|
33
|
Coronary artery pseudoaneurysm: closure with pericardium-covered stents, guided by cardiac computed tomography angiography.
|
Can J Cardiol
|
2013
|
0.75
|
|
34
|
Endothelial dysfunction and reduced myocardial perfusion reserve in heart failure secondary to coronary artery disease.
|
Am J Cardiol
|
2003
|
0.75
|